| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |